Saxenda

Obesity, at least one weight-related comorbid condition, Physical Activity + 6 more
Treatment
20 Active Studies for Saxenda

What is Saxenda

LiraglutideThe Generic name of this drug
Treatment SummaryVictoza is a medication containing liraglutide, a synthetic version of a human protein called glucagon-like peptide-1 (GLP-1). Liraglutide is very similar to GLP-1, with a slight difference in one amino acid. It also has a fatty acid and a glutamic acid attached to it. Victoza was approved by the FDA in 2010 and is used to help control blood sugar levels in people with type 2 diabetes.
Victozais the brand name
image of different drug pills on a surface
Saxenda Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Victoza
Liraglutide
2010
6

Effectiveness

How Saxenda Affects PatientsLiraglutide is a type of medicine designed to help treat type 2 diabetes, and is taken as a single dose daily. It works by attaching a fatty acid molecule to position 26 of the GLP-1 molecule, which allows it to bind to albumin in the bloodstream and subcutaneous tissue, and be released slowly over time. This reduces how quickly liraglutide is broken down and removed from the body. It helps to increase the secretion of insulin in response to glucose and slows down the emptying of the stomach. Additionally, it does not cause an increase in glucagon secretion when blood sugar levels
How Saxenda works in the bodyLiraglutide is a medication that helps control blood sugar levels. It is a synthetic version of a natural hormone called glucagon-like peptide-1. Liraglutide binds to the glucagon-like peptide-1 receptor, which causes the body to release insulin and reduce its release of glucagon. It also slows down digestion, helping to regulate blood sugar levels.

When to interrupt dosage

The recommended measure of Saxenda is contingent upon the diagnosed condition, including Diet, inadequate control on monotherapy and Disease. The measure of dosage changes per the technique of delivery (e.g. Injection, solution - Subcutaneous or Injection) featured in the table underneath.
Condition
Dosage
Administration
Major Adverse Cardiovascular Events
, 6.0 mg/mL, 3.6 mg/mL
Subcutaneous, Solution, , Solution - Subcutaneous, Injection, solution, Injection, solution - Subcutaneous, Injection, Injection - Subcutaneous
Obesity
, 6.0 mg/mL, 3.6 mg/mL
Subcutaneous, Solution, , Solution - Subcutaneous, Injection, solution, Injection, solution - Subcutaneous, Injection, Injection - Subcutaneous
at least one weight-related comorbid condition
, 6.0 mg/mL, 3.6 mg/mL
Subcutaneous, Solution, , Solution - Subcutaneous, Injection, solution, Injection, solution - Subcutaneous, Injection, Injection - Subcutaneous
Physical Activity
, 6.0 mg/mL, 3.6 mg/mL
Subcutaneous, Solution, , Solution - Subcutaneous, Injection, solution, Injection, solution - Subcutaneous, Injection, Injection - Subcutaneous
Type 2 Diabetes
, 6.0 mg/mL, 3.6 mg/mL
Subcutaneous, Solution, , Solution - Subcutaneous, Injection, solution, Injection, solution - Subcutaneous, Injection, Injection - Subcutaneous
Obesity
, 6.0 mg/mL, 3.6 mg/mL
Subcutaneous, Solution, , Solution - Subcutaneous, Injection, solution, Injection, solution - Subcutaneous, Injection, Injection - Subcutaneous
Diet
, 6.0 mg/mL, 3.6 mg/mL
Subcutaneous, Solution, , Solution - Subcutaneous, Injection, solution, Injection, solution - Subcutaneous, Injection, Injection - Subcutaneous
Chronic Weight Management therapy
, 6.0 mg/mL, 3.6 mg/mL
Subcutaneous, Solution, , Solution - Subcutaneous, Injection, solution, Injection, solution - Subcutaneous, Injection, Injection - Subcutaneous
Cardiovascular Diseases
, 6.0 mg/mL, 3.6 mg/mL
Subcutaneous, Solution, , Solution - Subcutaneous, Injection, solution, Injection, solution - Subcutaneous, Injection, Injection - Subcutaneous

Warnings

Saxenda Contraindications
Condition
Risk Level
Notes
Multiple Endocrine Neoplasia
Do Not Combine
Thyroid Neoplasms
Do Not Combine
Medullary carcinoma of thyroid
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Liraglutide may interact with Pulse Frequency
There are 20 known major drug interactions with Saxenda.
Common Saxenda Drug Interactions
Drug Name
Risk Level
Description
2,4-thiazolidinedione
Moderate
The risk or severity of hypoglycemia can be increased when Liraglutide is combined with 2,4-thiazolidinedione.
AICA ribonucleotide
Moderate
The risk or severity of hypoglycemia can be increased when Liraglutide is combined with AICA ribonucleotide.
AMG-222
Moderate
The risk or severity of hypoglycemia can be increased when Liraglutide is combined with AMG-222.
Acetohexamide
Moderate
Liraglutide may increase the hypoglycemic activities of Acetohexamide.
Albiglutide
Moderate
The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Albiglutide.
Saxenda Toxicity & Overdose RiskLiraglutide is safe and effective for people of all races, genders, and ages. However, elderly patients may be more likely to experience side effects. Women are more likely to have reduced clearance of liraglutide, but no dosage adjustment is necessary. The safety and benefits of liraglutide must be weighed before prescribing it to pregnant or breastfeeding women, as there is a risk of birth defects and the drug may be present in breast milk. Liraglutide has not been studied in pediatric or very obese patients or in those with end-stage renal or hepatic disease, so
image of a doctor in a lab doing drug, clinical research

Saxenda Novel Uses: Which Conditions Have a Clinical Trial Featuring Saxenda?

238 active clinical trials are currently underway to evaluate the potential of Saxenda in the treatment of Diseases, Physical Activity and Diet-related issues.
Condition
Clinical Trials
Trial Phases
Cardiovascular Diseases
0 Actively Recruiting
Type 2 Diabetes
177 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4, Early Phase 1
Obesity
0 Actively Recruiting
Obesity
0 Actively Recruiting
Chronic Weight Management therapy
0 Actively Recruiting
Physical Activity
35 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Early Phase 1
Major Adverse Cardiovascular Events
0 Actively Recruiting
Diet
5 Actively Recruiting
Not Applicable, Phase 1
at least one weight-related comorbid condition
0 Actively Recruiting

Saxenda Reviews: What are patients saying about Saxenda?

5Patient Review
11/10/2022
Saxenda for Weight Loss Management for an Obese Person
I started using this treatment a week ago and I'm already down 4.6 kg. I'm really surprised at how well it works with almost no side effects. The only issue I have is a dry mouth for a few hours after, but it's worth it since I have no desire to eat whatsoever.
5Patient Review
9/18/2022
Saxenda for Weight Loss Management for Overweight Person with BMI 27 to 29 and Weight-Related Comorbidity
I'm on my second week of Saxenda and have lost 7lbs already. I find that by going low and slow with the dosage increases, I don't experience any negative side effects like nausea or wind. Additionally, my reduced appetite and lack of sugar cravings are extremely helpful in maintaining a healthy weight loss.
5Patient Review
11/10/2022
Saxenda for Weight Loss Management for an Obese Person
This treatment has been a game-changer for me. I've always struggled with feeling full and satisfied after eating, but since starting this medication, that's no longer an issue. I definitely recommend it if you're looking for something to help control your appetite.
4.7Patient Review
10/20/2022
Saxenda for Weight Loss Management for an Obese Person
I was really pleased with how much weight I lost in the first two weeks- 11 pounds! And, it curbed my appetite so that I was making healthier choices without feeling deprived. The only downside is that I sometimes felt nauseous or got headaches, but those have gone away now. Always drink lots of fluids!
4.3Patient Review
10/20/2022
Saxenda for Weight Loss Management for Overweight Person with BMI 27 to 29 and Weight-Related Comorbidity
I've only been taking Saxenda for a short time, but I've already lost five pounds! The first few days were tough as my body adjusted to the medication. I experienced a lot of nausea and had to keep burping. Drinking lots of liquids helped a lot, as did changing my diet. Now that I'm more used to the medication, I haven't had any problems with constipation or diarrhea (as long as I keep my meals light).
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about saxenda

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does Saxenda work immediately?

"This means that it mimics the way that GLP-1 works to decrease appetite and promote fullness.

Some people may feel the effects of Saxenda within the first 1-3 days after taking it, but any weight loss is likely not to be noticeable for a little while. Saxenda contains Liraglutide which is a GLP-1 receptor agonist. This means that it works similarly to GLP-1 to decrease appetite and promote fullness."

Answered by AI

Does Saxenda work for weight loss?

"After one year of taking Saxenda®, 56% of patients achieved significant weight loss, and about half of these patients were able to maintain their weight loss for three years when combined with a reduced-calorie meal plan and increased physical activity."

Answered by AI

How quickly do you lose weight with Saxenda?

"Patients can expect to lose at least 5% of their weight within the first 12 weeks of treatment."

Answered by AI

Does Saxenda weight loss work?

"The Saxenda clinical study found that 56% of participants lost significant weight in the first year, and half of those participants were able to maintain their weight loss for the following two years while taking Saxenda and following a reduced-calorie meal plan and increased physical activity."

Answered by AI

What are the side effects of Saxenda?

"Some of the more common side effects that people experience when taking Saxenda® include nausea, diarrhea, constipation, vomiting, reactions at the injection site, low blood sugar levels (hypoglycemia), headaches, tiredness, dizziness, and stomach pain. Another thing that some people may experience is a change in the level of enzymes (lipase) in their blood."

Answered by AI

Is Saxenda just insulin?

"No, Saxenda is not a type of insulin. Insulin is a hormone that helps the body regulate blood sugar levels. Instead, Saxenda is a type of drug called a GLP-1 agonist. GLP-1 is another hormone that helps regulate blood sugar levels."

Answered by AI

Clinical Trials for Saxenda

Have you considered Saxenda clinical trials? We made a collection of clinical trials featuring Saxenda, we think they might fit your search criteria.
Have you considered Saxenda clinical trials? We made a collection of clinical trials featuring Saxenda, we think they might fit your search criteria.
Have you considered Saxenda clinical trials? We made a collection of clinical trials featuring Saxenda, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top